Thanks. Yes. Thanks, Armand. So Tobii's net sales grew by 8% in the quarter. Very much thanks to the acquisition, which contributed 25% to the overall growth, while the organic growth was -16%. EBIT in the quarter was -$66 million and contained $10 million, of course, related to redundancies, without which the EBIT would have been $56 million. With the 8% growth in the quarter. The net sales totaled $201 million, compared to $185 million last year. This is the first quarter where the acquisition of AutoSense was part of Tobii. During the whole quarter, the acquisition closed on the 31st of January. So in Q1, we only had February and March consolidated. Total net sales for January to June grew by 3% and totaled $362 million compared to $353 million last year. The organic growth in the quarter was -16%, stemming from both segments, products and solutions and integrations. And the organic growth for the first half of the year. It was -12%, mainly stemming from the products and solutions segment. The acquisition contributed 25% growth in the quarter and 17% for the first half of the year. The majority of the net sales from the acquisition in the quarter was attributed to the integration segment. This is a pattern that will continue during the fall, but when going into 2025, the integration net sales from the acquisition will decline. The gross margin was 79%, compared to 77% last year, where the product mix effect drove the margin upwards. The EBIT in the quarter was -$66 million, compared to -$48 million last year. Now, given the reality of both a larger organization through the acquisition, with possibilities for synergies and the weaker demand, we are now concentrating on significantly reducing our cost base. That is, in order to secure that we are operating within our available cash resources going forward. The current cost measures are predicted to reduce cash-related operational expenses by approximately $200 million over the next four quarters. These actions are of the highest priority for us, and I will return to this topic later in the presentation. As a result of these cost reduction actions, we have taken extraordinary costs relating to redundancy in the quarter of around $10 million, without which the EBIT would have been -56 million SEK. The year to date was -140 million SEK, or -130 million SEK, when adjusting for the run of costs, compared to -101 million SEK last year.
And now moving on to the products and solutions segment, the largest within Tobii with 54% of net sales, it had another weak quarter with an organic growth of -15%. We saw continued weaker demand in Asia, but this quarter's negative development should also be viewed in the context of an exceptionally strong quarter last year, with 31% growth year to date. The organic growth for the quarter was the same as the annual rate, which is -15%. The gross margin in the quarter was 66%, compared to 71% last year. The combination of product mix and negative scale effects from lower volumes drove the margin down.
The margin year to date was 65%, compared to 70% last year, with the same logic for the variation. The EBIT for products and solutions was -26 million SEK. This quarter and year to date, the EBIT was -49 million SEK. Of course, this is not an acceptable level in this more mature segment. And therefore we continue to take cost reduction actions.
The integration segment, which accounted for 42% of Tobii's net sales in the quarter, experienced total growth of 52%. The organic growth was -16%, affected by quarterly variations, and the acquisition contributed 68%. As mentioned before, the majority of the net sales from the acquisition in this quarter were attributed to the integration segment. The level of these additional sales will decrease entering 2025. Year to date, net sales growth was 48%, of which organic was -3%, and from the acquisition +51%; the gross margin was 96%, compared to 92% last year, both in the quarter and year to date.
The outcome was a result of higher share of software and services. The EBIT in the quarter was a positive $21 million, and thus the year to date EBIT was a positive $7,060,000. So the ultrasound segment, which is still in an investment phase, had a net sales of $9 million in the quarter, mainly stemming from the acquisition. Year to date, the net sales were $15 million. The gross margin was 91% in the quarter, somewhat lower compared to last year's 97%.
And then, with the numerator and the denominator still being very low, percentage points change quickly when you add a bit to the cost of goods sold and services, as we did this quarter; year to March the gross margin was 95% compared to 94% last year. The high gross margin reflects the high level of software and services in this segment. The EBIT was -60 million in the quarter and -99 million year to date. And then looking at the balances and cash flow. The free cash flow from continuous investments was -125 million this quarter and -251 million year to date, compared to -67 million in the quarter last year and -20 million year to date. While last year's Q1 was positively affected by 63 million in temporary Covid-related tax reliefs in the quarter, a rights issue was completed with a net of $267 million. The cash position at the end of the quarter was 244 million SEK, and in addition, we have an unutilized revolving credit facility of 50 million SEK. Of course, we cannot continue to consume cash at this pace going forward as we have done in these past two quarters, and we certainly do not intend to do so either. And that conclusion is a suitable bridge to my next slide around costs and operational efficiency.
When we acquired Autosense, we were very much aware that we would start out with high costs and low net sales from this new segment, and we planned to work our way forward from that. In addition to this already known fact for the spring, we have also underperformed during the first half year in our products and solutions segment. So what are we doing? Well, besides driving business development to secure higher net sales, we have an expanded cost reduction program going on which we are executing on to ensure that we continue to operate within the existing cash resources. We are breaking the cost reduction program down into three buckets. The first bucket is our product investments, which sums up the research and development expenses in the PNL and CapEx.
Here, we are prioritizing hard on which products to cut development on, which products to only maintain, and which products to exit. The second bucket is the rest of the organization, which sums up the sales and marketing and administrative expenses in the PNL. Here, we have done reorganizations and new prioritizations, while at the same time securing the efficiency effects from working more streamlined globally and with a higher degree of low touch sales. And then the third bucket. That is where the realization of synergies from the acquisition is sorted.
As I mentioned earlier, for this bucket, we already had plans for how to proceed with the closing of the acquisition, and now we are executing on these plans. The effect from this work will also be seen in the research and development expenses and CapEx. All in all, the work we are doing in these three buckets will reduce the cash related operational expenses by approximately $200 million for the coming four quarters, using Q2 2024 as the baseline. And when we talk about cash related expenses, we mean expenses without depreciation but including CapEx. And we use these terms since it's close to the cash, which is what we are focusing on here.
In practice, this means that the expenses that will be seen in the PNL going forward will not be reduced as much as the cash related expenses will. And that is for two reasons. One, because when we reduce the engineering development expenses, they are normally capitalized. And that's not seen in the PNL directly. The second reason is that going forward, depreciation will increase once different parts of the products within the Autosense segments are ready and we start to get licensed revenue from design wins.
We will also start depreciation on these products. And so in addition to this short term profitability and cash improvement focus, we are of course very much committed to our long term financial goals, which we introduced earlier this year and for which the short term development improvement builds the foundation. We are thus working to secure a positive free cash flow for the full year of 2026, and an EBIT margin of around 10% for the full year of 2026, followed by an EBIT margin of around 20% for the full year of 2028. And with that, over to you, Ana. And also that one.